title: Gram-positive marine bacteria as a potential resource for the discovery of quorum sensing inhibitors.
abstract: Inhibitors of bacterial quorum sensing have been proposed as potentially novel therapeutics for the treatment of certain bacterial diseases. We recently reported a marine Halobacillus salinus isolate that secretes secondary metabolites capable of quenching quorum sensing phenotypes in several Gram-negative reporter strains. To investigate how widespread the production of such compounds may be in the marine bacterial environment, 332 Gram-positive isolates from diverse habitats were tested for their ability to interfere with Vibrio harveyi bioluminescence, a cell signaling-regulated phenotype. Rapid assay methods were employed where environmental isolates were propagated alongside the reporter strain. "Actives" were defined as bacteria that interfered with bioluminescence without visible cell-killing effects (antibiotic activity). A total of 49 bacterial isolates interfered with bioluminescence production in the assays. Metabolite extracts were generated from cultures of the active isolates, and 28 reproduced the bioluminescence inhibition against V. harveyi. Of those 28, five extracts additionally inhibited violacein production by Chromobacterium violaceum. Chemical investigations revealed that phenethylamides and a cyclic dipeptide are two types of secondary metabolites responsible for the observed activities. The active bacterial isolates belonged primarily to either the genus Bacillus or Halobacillus. The results suggest that Gram-positive marine bacteria are worthy of further investigation for the discovery of quorum sensing antagonists.
authors.affiliation: Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI 02881, USA.
authors.forename: Margaret E
authors.initials: ME
authors.lastname: Teasdale
authors.forename: Kellye A
authors.initials: KA
authors.lastname: Donovan
authors.forename: Stephanie R
authors.initials: SR
authors.lastname: Forschner-Dancause
authors.forename: David C
authors.initials: DC
authors.lastname: Rowley
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000302:isolation & purification / Q000494:pharmacology*; D059001:Aquatic Organisms / Q000737:chemistry*; D001406:Bacillaceae / Q000737:chemistry*; D001444:Bahamas; D001483:Base Sequence; D002861:Chromobacterium / Q000737:chemistry; D016000:Cluster Analysis; D017931:DNA Primers / Q000235:genetics; D019015:Geologic Sediments / Q000382:microbiology*; D007211:Indoles / Q000037:antagonists & inhibitors; D007448:Invertebrates / Q000382:microbiology*; D008164:Luminescent Proteins / Q000378:metabolism; D008969:Molecular Sequence Data; D009511:New England; D010802:Phylogeny; D011647:Puerto Rico; D053038:Quorum Sensing / Q000187:drug effects*; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D017422:Sequence Analysis, DNA; D014733:Vibrio / Q000187:drug effects*
chemical_list: D000900:Anti-Bacterial Agents; D017931:DNA Primers; D007211:Indoles; D008164:Luminescent Proteins; D012336:RNA, Ribosomal, 16S; C063155:violacein